A Drug-Drug Interaction Study of Diltiazem and MK-1167 in Healthy Adult Participants (MK-1167-006)
Clinical trial NCT06703463 · COMPLETED
Trial details
- NCT number
- NCT06703463
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-17
- Primary completion
- 2024-02-02
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.